TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Ridgeview Diagnostics AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0 | |
| Financial expenses |
0
|
3 | |
| Earnings before taxes |
-245
|
-491 | |
| EBITDA |
-23
|
-14 | |
| Total assets |
574
|
818 | |
| Current assets |
394
|
456 | |
| Current liabilities |
0
|
1 | |
| Equity capital |
574
|
817 | |
| - share capital |
185
|
185 | |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
100%
|
99.9% | |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-42.7%
|
-59.7% | |
| Current ratio | 45600% | ||
| Return on equity (ROE) |
-42.7%
|
-60.1% | |
| Change turnover |
0
|
-150 | |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.